AEON Biopharma CEO Robert E. Bancroft reports acquisition of $19,590.0238 in common shares
AEON•AEON Biopharma CEO Robert E. Bancroft purchased 152,333 Class A common shares at $0.1286 each, bringing his direct holdings to 3,329,436 shares.
AEON•AEON Biopharma CEO Robert E. Bancroft purchased 152,333 Class A common shares at $0.1286 each, bringing his direct holdings to 3,329,436 shares.
Robert E. Bancroft purchased 152,333 shares of AEON Biopharma Class A common stock at $0.1286 per share, a total of $19,590.0238. His direct holdings rose to 3,329,436 shares.